ES2694111T3 - Aparato médico - Google Patents
Aparato médico Download PDFInfo
- Publication number
- ES2694111T3 ES2694111T3 ES14758632.5T ES14758632T ES2694111T3 ES 2694111 T3 ES2694111 T3 ES 2694111T3 ES 14758632 T ES14758632 T ES 14758632T ES 2694111 T3 ES2694111 T3 ES 2694111T3
- Authority
- ES
- Spain
- Prior art keywords
- medical device
- light
- radiation
- patient
- scotopic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000005855 radiation Effects 0.000 claims abstract description 35
- 230000005670 electromagnetic radiation Effects 0.000 claims abstract description 20
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims abstract description 10
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims abstract description 10
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims abstract description 10
- 230000014509 gene expression Effects 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 11
- 230000001815 facial effect Effects 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 230000003287 optical effect Effects 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 210000004204 blood vessel Anatomy 0.000 description 24
- 210000001525 retina Anatomy 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 206010012689 Diabetic retinopathy Diseases 0.000 description 10
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 230000004438 eyesight Effects 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- 238000000151 deposition Methods 0.000 description 7
- 208000000208 Wet Macular Degeneration Diseases 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 206010025421 Macule Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 208000002780 macular degeneration Diseases 0.000 description 5
- 230000036284 oxygen consumption Effects 0.000 description 5
- 230000006978 adaptation Effects 0.000 description 4
- 206010064930 age-related macular degeneration Diseases 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 206010012688 Diabetic retinal oedema Diseases 0.000 description 3
- 229910002601 GaN Inorganic materials 0.000 description 3
- 229920000144 PEDOT:PSS Polymers 0.000 description 3
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 201000011190 diabetic macular edema Diseases 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 208000019116 sleep disease Diseases 0.000 description 3
- 208000022925 sleep disturbance Diseases 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 238000007646 gravure printing Methods 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 2
- 229910003437 indium oxide Inorganic materials 0.000 description 2
- 229910052741 iridium Inorganic materials 0.000 description 2
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000000608 photoreceptor cell Anatomy 0.000 description 2
- 108091008695 photoreceptors Proteins 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000012672 seasonal affective disease Diseases 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 229910001887 tin oxide Inorganic materials 0.000 description 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- GEQBRULPNIVQPP-UHFFFAOYSA-N 2-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole Chemical compound C1=CC=CC=C1N1C2=CC=CC=C2N=C1C1=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=C1 GEQBRULPNIVQPP-UHFFFAOYSA-N 0.000 description 1
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- JMASRVWKEDWRBT-UHFFFAOYSA-N Gallium nitride Chemical compound [Ga]#N JMASRVWKEDWRBT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 201000007917 background diabetic retinopathy Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004155 blood-retinal barrier Anatomy 0.000 description 1
- 230000004378 blood-retinal barrier Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000004300 dark adaptation Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007607 die coating method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 238000000407 epitaxy Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002102 hyperpolarization Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000018769 loss of vision Diseases 0.000 description 1
- 231100000864 loss of vision Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 210000003668 pericyte Anatomy 0.000 description 1
- 230000004310 photopic vision Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000004439 pupillary reactions Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003994 retinal ganglion cell Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000004296 scotopic vision Effects 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- PBCFLUZVCVVTBY-UHFFFAOYSA-N tantalum pentoxide Inorganic materials O=[Ta](=O)O[Ta](=O)=O PBCFLUZVCVVTBY-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002207 thermal evaporation Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 230000004862 vasculogenesis Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
- A61N2005/0627—Dose monitoring systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
- A61N2005/0648—Applicators worn by the patient the applicator adapted to be worn on the head the light being directed to the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0653—Organic light emitting diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0656—Chemical light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
- A61N2005/0667—Filters
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1315836.5A GB201315836D0 (en) | 2013-09-05 | 2013-09-05 | Medical apparatus and method |
| GB201315836 | 2013-09-05 | ||
| PCT/GB2014/052627 WO2015033114A1 (en) | 2013-09-05 | 2014-08-29 | Medical apparatus and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2694111T3 true ES2694111T3 (es) | 2018-12-18 |
Family
ID=49486795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14758632.5T Active ES2694111T3 (es) | 2013-09-05 | 2014-08-29 | Aparato médico |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10888709B2 (enExample) |
| EP (1) | EP3041575B1 (enExample) |
| JP (1) | JP6473754B2 (enExample) |
| KR (1) | KR102508596B1 (enExample) |
| CN (1) | CN105682737B (enExample) |
| AU (1) | AU2014316860B2 (enExample) |
| BR (1) | BR112016004943B1 (enExample) |
| CA (1) | CA2959869C (enExample) |
| DK (1) | DK3041575T3 (enExample) |
| ES (1) | ES2694111T3 (enExample) |
| GB (1) | GB201315836D0 (enExample) |
| MX (1) | MX360241B (enExample) |
| PL (1) | PL3041575T3 (enExample) |
| PT (1) | PT3041575T (enExample) |
| SG (1) | SG11201601684PA (enExample) |
| SI (1) | SI3041575T1 (enExample) |
| TR (1) | TR201816306T4 (enExample) |
| TW (1) | TWI673081B (enExample) |
| WO (1) | WO2015033114A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201315836D0 (en) * | 2013-09-05 | 2013-10-23 | Polyphotonix Ltd | Medical apparatus and method |
| US10512534B2 (en) | 2016-10-03 | 2019-12-24 | California Institute Of Technology | Radioluminescent phototherapy eye device |
| WO2019152526A1 (en) | 2018-01-31 | 2019-08-08 | California Institute Of Technology | Controllable ocular phototherapy |
| EP3542857A1 (en) * | 2018-03-19 | 2019-09-25 | Rucker, Frances Joan | Balanced cone excitation for controlling refractive error and ocular growth to inhibit development of myopia |
| CA3118281C (en) * | 2018-10-30 | 2022-06-14 | Multi Radiance Medical | Photobiomodulation therapy to treat a degenerative condition of the retina and/or the optic nerve |
| US11666485B2 (en) * | 2019-03-01 | 2023-06-06 | LumosTech, Inc. | Adjustable mask |
| CN114870275A (zh) * | 2022-05-24 | 2022-08-09 | 深圳市雏鹰视界健康科技有限公司 | 一种眼部智能生物视光仪和眼睛训练方法 |
| CN120000146B (zh) * | 2024-09-27 | 2025-10-17 | 中国人民解放军空军军医大学 | 一种快速中间视觉暗适应功能检查方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3044184A1 (de) * | 1980-11-24 | 1982-06-16 | Mutzhas Maximilian F | Vorrichtung zur phototherapeutischen behandlung der hyperbilirubinaemie |
| US5015924A (en) * | 1989-04-14 | 1991-05-14 | The United States Of America As Represented By The United States Department Of Energy | Pupillary efficient lighting system |
| US7678140B2 (en) | 2000-05-10 | 2010-03-16 | George Brainard | Photoreceptor system for melatonin regulation and phototherapy |
| US7015636B2 (en) * | 2002-10-23 | 2006-03-21 | Charles Bolta | Balanced blue spectrum therapy lighting |
| US20040225340A1 (en) * | 2003-03-10 | 2004-11-11 | Evans James W. | Light/breath/meditation device |
| JP4630864B2 (ja) | 2003-05-01 | 2011-02-09 | フリンダーズ パートナーズ ピーティワイ リミテッド | 光刺激を与えるための装置 |
| US20050278003A1 (en) * | 2004-05-12 | 2005-12-15 | Harold Feldman | Electroluminescent light therapy devices |
| US20100081185A1 (en) | 2004-08-17 | 2010-04-01 | Mcdaniel David H | System and method for photodynamic cell therapy |
| JP2008237618A (ja) * | 2007-03-27 | 2008-10-09 | Toin Gakuen | 光力学的治療用光照射装置 |
| KR20100027186A (ko) | 2007-05-31 | 2010-03-10 | 코닌클리즈케 필립스 일렉트로닉스 엔.브이. | 조명 및 생리적 자극 제공 방법 및 시스템 |
| ATE535754T1 (de) * | 2007-07-26 | 2011-12-15 | Innolumis Public Lighting B V | STRAßENBELEUCHTUNGSANORDNUNG |
| JP2010162214A (ja) * | 2009-01-16 | 2010-07-29 | Kagoshima Univ | 光照射装置 |
| CA2756668A1 (en) * | 2009-03-25 | 2010-09-30 | High Performance Optics, Inc. | Photochromic ophthalmic systems that selectively filter specific blue light wavelengths |
| JP5808318B2 (ja) * | 2009-04-24 | 2015-11-10 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 被験者の眼球に電磁放射を送達するシステム |
| GB201007256D0 (en) | 2010-04-30 | 2010-06-16 | Polyphotonix Ltd | Radiation treatment apparatus |
| CN102905750B (zh) * | 2010-05-14 | 2016-04-06 | 皇家飞利浦电子股份有限公司 | 用于使用两个或更多波长段的电磁辐射给受试者提供光疗的系统 |
| JP5993844B2 (ja) | 2010-05-14 | 2016-09-14 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 睡眠マスクを用いる効率的な概日系及び間連する系の調節 |
| EP2422844A1 (en) | 2010-08-24 | 2012-02-29 | Polyphotonix Limited | Wearable phototherapy device |
| EP2422845B1 (en) | 2010-08-24 | 2013-04-24 | Polyphotonix Limited | Lightguide phototherapy apparatus |
| GB201104369D0 (en) | 2011-03-15 | 2011-04-27 | English Stuart G | Light treatment cartridge |
| WO2012174245A1 (en) * | 2011-06-14 | 2012-12-20 | Children's Hospital Medical Center | Devices and treatment methods for vascular eye di |
| US9278029B2 (en) | 2011-10-19 | 2016-03-08 | Iridex Corporation | Short duration pulse grid pattern laser treatment and methods |
| US20140257439A1 (en) * | 2013-03-06 | 2014-09-11 | Verilux, Inc. | Adjustable therapeutic lights |
| GB201315836D0 (en) * | 2013-09-05 | 2013-10-23 | Polyphotonix Ltd | Medical apparatus and method |
-
2013
- 2013-09-05 GB GBGB1315836.5A patent/GB201315836D0/en not_active Ceased
-
2014
- 2014-08-29 BR BR112016004943-8A patent/BR112016004943B1/pt active IP Right Grant
- 2014-08-29 CN CN201480060273.3A patent/CN105682737B/zh active Active
- 2014-08-29 SI SI201430938T patent/SI3041575T1/sl unknown
- 2014-08-29 PL PL14758632T patent/PL3041575T3/pl unknown
- 2014-08-29 ES ES14758632.5T patent/ES2694111T3/es active Active
- 2014-08-29 US US14/916,863 patent/US10888709B2/en active Active
- 2014-08-29 AU AU2014316860A patent/AU2014316860B2/en active Active
- 2014-08-29 MX MX2016002874A patent/MX360241B/es active IP Right Grant
- 2014-08-29 SG SG11201601684PA patent/SG11201601684PA/en unknown
- 2014-08-29 TR TR2018/16306T patent/TR201816306T4/tr unknown
- 2014-08-29 PT PT14758632T patent/PT3041575T/pt unknown
- 2014-08-29 DK DK14758632.5T patent/DK3041575T3/en active
- 2014-08-29 CA CA2959869A patent/CA2959869C/en active Active
- 2014-08-29 WO PCT/GB2014/052627 patent/WO2015033114A1/en not_active Ceased
- 2014-08-29 KR KR1020167009030A patent/KR102508596B1/ko active Active
- 2014-08-29 EP EP14758632.5A patent/EP3041575B1/en active Active
- 2014-08-29 JP JP2016539631A patent/JP6473754B2/ja active Active
- 2014-09-02 TW TW103130235A patent/TWI673081B/zh active
-
2020
- 2020-07-13 US US16/927,072 patent/US11654296B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX360241B (es) | 2018-10-26 |
| CN105682737B (zh) | 2018-05-08 |
| BR112016004943A2 (pt) | 2017-08-01 |
| DK3041575T3 (en) | 2018-11-26 |
| US10888709B2 (en) | 2021-01-12 |
| PL3041575T3 (pl) | 2019-03-29 |
| SI3041575T1 (sl) | 2018-12-31 |
| JP6473754B2 (ja) | 2019-02-20 |
| CA2959869A1 (en) | 2015-03-12 |
| TWI673081B (zh) | 2019-10-01 |
| CN105682737A (zh) | 2016-06-15 |
| AU2014316860A1 (en) | 2016-04-28 |
| KR20160064126A (ko) | 2016-06-07 |
| US11654296B2 (en) | 2023-05-23 |
| US20200346031A1 (en) | 2020-11-05 |
| US20160220841A1 (en) | 2016-08-04 |
| TW201513911A (zh) | 2015-04-16 |
| GB201315836D0 (en) | 2013-10-23 |
| KR102508596B1 (ko) | 2023-03-10 |
| MX2016002874A (es) | 2016-06-22 |
| EP3041575A1 (en) | 2016-07-13 |
| EP3041575B1 (en) | 2018-08-08 |
| TR201816306T4 (tr) | 2018-11-21 |
| WO2015033114A1 (en) | 2015-03-12 |
| AU2014316860B2 (en) | 2019-05-16 |
| BR112016004943B1 (pt) | 2021-08-17 |
| CA2959869C (en) | 2021-12-28 |
| SG11201601684PA (en) | 2016-04-28 |
| PT3041575T (pt) | 2018-11-20 |
| JP2016529056A (ja) | 2016-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2694111T3 (es) | Aparato médico | |
| Choi et al. | Wearable Photomedicine for Neonatal Jaundice Treatment Using Blue Organic Light‐Emitting Diodes (OLEDs): Toward Textile‐Based Wearable Phototherapeutics | |
| US20230118068A1 (en) | Device to prevent retinal hypoxia | |
| US20170100607A1 (en) | Fibers in therapy and cosmetics | |
| JP2012514498A5 (enExample) | ||
| Chang et al. | In vitro and in vivo efficacy of new blue light emitting diode phototherapy compared to conventional halogen quartz phototherapy for neonatal jaundice | |
| US20220233878A1 (en) | Light source for eye therapy and light emitting device having the same | |
| BR8302354U (pt) | Aperfeiçoamento introduzido em fonte de luz fototerápica para tratamento da hiperbilirrubinemia | |
| BR112020002313A2 (pt) | sistema e método para direcionar a luz no olho do paciente | |
| JP2018134406A (ja) | 運動関連の神経疾患を治療する、および／または診断するための発光装置 | |
| ES2836785T3 (es) | Aparatos para tratar y/o diagnosticar trastornos neurológicos psicomotores | |
| WO2020058549A1 (es) | Lente oftálmica para conversión espectral de la luz y método para fabricarla | |
| CN108337881A (zh) | 治疗皮肤病症的小型uvb光疗装置 | |
| US12377286B2 (en) | Anti-infective and therapeutic electromagnetic emission methods and devices | |
| TW202203869A (zh) | 具紅光及近紅外光多波段眼部活化裝置及其操作方法 | |
| HK1210976B (zh) | 一种用於患有与运动相关的神经疾病的对象的系统 |